Question from Deputy Ken O’Flynn - PQ 39068-26
Deputy O'Flynn asked about the clinical impact of reimbursement delays for patients with progressive neurological conditions. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the clinical impact of reimbursement delays for patients with progressive neurological conditions. Read the HSE response.
Deputy O'Flynn asked if the performance of agency staffing suppliers are monitored nationally. Read the HSE response.
Deputy Kenny asked about the cost of establishing each integrated healthcare area. Read the HSE response.
Deputy O'Flynn asked a number of questions regarding the diagnosis and treatment of lyme disease. Read the HSE response.
Deputy O'Flynn asked about the absence of national audit or outcome-monitoring systems in any healthcare pathway has been recorded on a HSE risk register.
Deputy O'Flynn asked if the HSE maintains a centralised national system relating to agency or locum healthcare workers across HSE-funded services.
Deputy O'Flynn asked about any assessment of the long-term financial impact of increasing reliance on the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked about value-for-money assessment before approval of high-cost treatment abroad scheme referrals. Read the HSE response.
Deputy O'Flynn asked about formal written financial approval thresholds for expenditure under the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked if the HSE maintains a national register of data-quality incidents. Read the HSE response.